Related Experiment Video
Updated: May 22, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
[Resistance studies: when are they indicated?]
1Servicio de Microbiología, Hospital Clínic de Barcelona, Barcelona, España. mmarcos@clinic.ub.es
Abstract:
Cytomegalovirus (CMV) resistance to antiviral drugs is an emerging problem and is due to selection of mutations in the viral genome. Although ganciclovir resistance is the most common and widely studied, there is resistance to all antiviral agents. Risk factors for the development of resistance are the absence of preexisting immunity to CMV, lung and pancreas transplantation, high viral loads, intense concomitant immunosuppressive therapy and prolonged exposure to ganciclovir or suboptimal levels of this drug. Antiviral resistance should be suspected when, despite adequate treatment exposure for 2 weeks, an increase in viral load, or persistence or clinical progression of CMV disease are detected. However, failure to respond cannot always be attributed to antiviral resistance nor does resistance always lead to poor clinical outcome. When resistance is suspected, phenotypic and genotypic confirmation is required. The most common mutations are those in the UL97 gene, which confers ganciclovir resistance. However, foscarnet and cidofovir can be used. The UL54 mutation is not uncommon, whether alone or in combination with UL97 mutations. The combination of UL54 and UL97 mutations is associated with high-grade and multiple resistance. Early detection of resistance is essential to prevent unfavorable outcome and the development of multi-drug resistance. In patients with a slow response to treatment and without mutations associated with resistance, plasma ganciclovir levels and specific CMV immunity should be investigated.
Insights
Cytomegalovirus (CMV) drug resistance is a growing concern due to viral mutations. Early detection of resistance, particularly UL97 and UL54 mutations, is crucial for effective treatment and preventing multi-drug resistance.
Area of Science:
- Virology
- Infectious Diseases
- Pharmacology
Context:
- Antiviral drug resistance in Cytomegalovirus (CMV) is an increasing clinical challenge.
- Resistance arises from mutations in the CMV genome, affecting all antiviral agents, with ganciclovir resistance being most studied.
- Risk factors include lack of immunity, specific transplant types, high viral loads, and prolonged/suboptimal antiviral exposure.
Purpose:
- To highlight the emerging problem of Cytomegalovirus (CMV) antiviral drug resistance.
- To identify risk factors and clinical indicators for suspecting CMV resistance.
- To emphasize the importance of early detection and confirmation of resistance mutations.
Summary:
- CMV resistance develops through mutations, primarily in UL97 (ganciclovir resistance) and UL54 genes, with combined mutations leading to high-grade, multi-drug resistance.
- Suspect resistance if viral load increases or disease progresses despite 2 weeks of adequate treatment.
- Phenotypic and genotypic testing are required for confirmation; alternative antivirals like foscarnet and cidofovir may be used.
Impact:
- Early detection of CMV resistance is essential to prevent poor clinical outcomes and the development of multi-drug resistant strains.
- Investigating plasma drug levels and immune status is important for patients with slow responses lacking resistance mutations.
- Understanding resistance mechanisms guides therapeutic strategies and improves patient management in CMV infections.
Related Concept Videos
Resistance
Treatment Resistant Cancers
Non-ohmic Devices
Consider a simple circuit consisting of a battery, a diode, and a resistor. A diode...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Resistivity
Resistors In Series
In a series circuit, the...
